Avac Event

AIDS Vaccine 2012

AIDS Vaccine is the largest global scientific conference focused exclusively on AIDS vaccine research. Hosted annually by the Global HIV Vaccine Enterprise and local partners, AIDS Vaccine brings together the scientific minds to exchange the latest research findings, explore new ideas, educate future leaders and engage a diverse community to help further research to develop a safe and effective HIV vaccine.

View the program here.

For more information, click here.


AIDS Vaccine Research: The latest news and conference details

This webinar featured leaders in the field providing updates on ongoing and planned efficacy trials, along with a review of the science behind neutralizing antibody research.

A recording is available here.

For background on each of these issues check out AVAC’s fact sheet series, AIDS Vaccine Science for Busy Advocates.


Symposia 04: Cross-cutting Issues in Clinical Trial Design

In a symposium on cross-cutting issues in trial design, presenters offered ideas on whether and how PrEP may be added to ongoing and planned AIDS vaccine trials, and the ethical and practical challenges of defining the standard of prevention offered to trial participants as new strategies are identified. Slides are available:

Good Participatory Practice (GPP) Guidelines

HIV Vaccines & Microbicides Resource Tracking


Each of the sessions in the conference program was webcast—see the full list here.

Our suggested webcast viewing is available here.

Additional coverage of AIDS Vaccine 2012 will appear in the forthcoming issue of Px Wire.